LOG IN
SIGN UP
MARKET
VERU
VERU
Veru
NASDAQ
1.080
+0.040
+3.85%
Closed 18:59 05/30 EDT
OPEN
1.040
PREV CLOSE
1.040
HIGH
1.090
LOW
1.030
VOLUME
861.57K
TURNOVER
--
52 WEEK HIGH
24.55
52 WEEK LOW
0.9337
MARKET CAP
96.38M
P/E (TTM)
-0.6261
1D
5D
1M
3M
1Y
5Y
Russell 3000 rejig: CPNG, JAKK among added, QRTEA, EXPR among deleted
Seeking Alpha · 6d ago
Veru Says Clinical Trial Of VERU-100 To Determine An Effective Dose Of VERU-100 For The Treatment Of Advanced Prostate Cancer Has Been Terminated As Endpoints Were Not Achieved At Current Dose Level
Benzinga · 05/19 15:42
Veru Has Been Granted U.S. Patent Number 11,648,236 Titled "Methods Of Treating Coronavirus"
Benzinga · 05/16 15:16
HC Wainwright & Co. Maintains Veru (VERU) Buy Recommendation
NASDAQ · 05/15 20:03
HC Wainwright & Co. Maintains Buy on Veru, Lowers Price Target to $2
Benzinga · 05/15 10:51
H.C. Wainwright Sticks to Its Buy Rating for Veru (VERU)
TipRanks · 05/15 10:25
--HC Wainwright Adjusts Price Target on Veru to $2 From $6, Maintains Buy Rating
--HC Wainwright Adjusts Price Target on Veru to $2 From $6, Maintains Buy Rating
MT Newswires · 05/15 08:34
BRIEF-Veru Inc Files Prospectus Related To Offering, Resale By Selling Shareholder Of Up To An Aggregate Of 5 Million Shares Of Common Stock - SEC Filing
Reuters · 05/12 20:57
About VERU
Veru Inc. is a biopharmaceutical company. The Company is focused on developing medicines for the for the treatment of hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome (ARDS) and other viral-related ARDS and for the management of breast and prostate cancers. The Company offers two FDA approved products within its sexual health program, including ENTADFI (tadalafil 5mg and finasteride 5mg capsule), for the treatment of benign prostatic hyperplasia and FC2 Female Condom (internal condom) (FC2), for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. Its breast cancer drug pipeline has four clinical development programs for two drugs, such as enobosarm, an oral selective androgen receptor targeting agonist, and sabizabulin, an oral cytoskeleton disruptor. Its prostate cancer drug pipeline includes sabizabulin, VERU-100 and zuclomiphene citrate.
Webull offers kinds of Veru Inc stock information, including NASDAQ:VERU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VERU stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading VERU stock methods without spending real money on the virtual paper trading platform.